NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ginkgo Bioworks

Ginkgo Bioworks

Public
Boston, MassachusettsBiotechhttps://www.ginkgobioworks.com

Last Round

IPO Announced

Sep 16, 2021

Est. Valuation

$16.63B

Total Funding Raised

$2.42B

Company Overview

Ginkgo Bioworks is a biotechnology company that offers comprehensive cell programming solutions to address challenges in various sectors, including food, agriculture, pharmaceuticals, and industrial chemicals.

Sector

Biotech

AI Layer

Infrastructure

Keywords

cell engineering platformsynthetic biology platform as a serviceautomated synthetic biology foundrybiological R&D servicesproprietary biological codebasecell programming as a servicebiosecurity and pathogen detection servicesenzyme discovery and optimization servicesorganism design and optimization servicesmodular lab automation hardware and softwareADME profiling for drug discoverydownstream value-sharing revenue modelgovernment biosecurity contract services

Ginkgo Bioworks Comps

Public and private peers based on sector, stage, and business model.

Ginkgo Bioworks comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ginkgo Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPO AnnouncedSep 16, 2021
Series E ExtensionMay 28, 2020
Series ESep 19, 2019
Series DDec 14, 2017
Series CJun 8, 2016
Series B
Jul 23, 2015

Ginkgo Bioworks Investors

Notable investors and investment history

Ginkgo Bioworks investors
InvestorRounds
Cascade Investment GroupSeries C, Series D
Cascade InvestmentSeries C, Series D, IPO, Series E
Massachusetts Development Finance AgencySeries A
Allen & Company LLCSeries C
Bellco CapitalIPO
ArrowMark PartnersIPO
Collaborative FundSeries A, Seed

Ginkgo Bioworks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ginkgo Bioworks Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2008
Last FundingSep 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.